insights_auto
Why is GERN down 5.34%?
Dive Deeperchevron_right
GERN:NASDAQ
Geron Corp
$1.24
arrow_downward
-5.34%(-0.070) 1D
$1.26
arrow_upward
+1.21% (+0.015)bedtimeAfter hours
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$1.33
High
$1.33
Low
$1.22
Mkt. cap
796.67M
Avg. vol.
10.01M
Volume
10.93M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
Open
$1.33
High
$1.33
Low
$1.22
Mkt. cap
796.67M
Avg. vol.
10.01M
Volume
10.93M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
News stories
From web sources and news partners
The Globe and Mail
·
13 hours ago
Analysts Offer Insights on NA Companies: Geron (GERN) and Fair Isaac (FICO)
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegeron.com